Logo Image
News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAI Pulse CheckAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions PodcastShorts
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPartnersPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksState of the ScienceWhitepapers
Event Calendar

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Event Calendar
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement

Quality Systems

Latest News

August 2nd 2001
Changes and Challenges for CDER
By Jill Wechsler

The Center for Drug Evaluation and Research is adopting new approaches to how it oversees the development and approval of new drugs and how it ensures the safe use of prescription drugs by the public.

July 1st 2001

The Role of USP in the Assessment of Microbiological Quality of Pharmaceuticals

July 1st 2001

The Future State of Computer Validation, Part I

By Rory Budihandojo
July 1st 2001

What Is the "Correct" Method to Use for Particle-Size Determination?

February 1st 1999

Reportable Values for Out-of-Specification Test Results

By Lynn D. Torbeck
Advertisement

Advertisement

Designed Experiments- A Vital Role in Validation

ByLynn D. Torbeck
June 1st 1998

Ruggedness and Robustness with Designed Experiments

ByLynn D. Torbeck
March 1st 1996
  • Prev
  • 1
  • More pages
  • 206
  • 207
  • 208
  • 209
  • 210
  • 211
  • 212
  • 213
  • 214
  • 215
  • Prev
Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

Can Continuous Tableting End Scale-Up for Complex Oral Drugs?

2

Manufacturing Intelligence: Organoids, Organ-on-a-Chip, and the Trust Gap

3

CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 1

4

PharmTech AI Pulse Check: On-Prem vs. Cloud AI

5

CPHI Milan: Packaging and Delivery Decisions Must Reflect Real-World Care

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us